Montenegro latest patents query
The latest invention patents collect the data information of Montenegro invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Process for the production of a chocolate snack and snack which can be obtained using this process
ActiveME03249BBiotechnologySnack food
Owner:BARILLA G E R F LLI SPA
Stabilized formulations containing Anti-interleukin-6 receptor (il-6r) antibodies
UndeterminedME03914BAntiendomysial antibodiesReceptor
Owner:REGENERON PHARMACEUTICALS INC
Bispecific antibody constructs binding dll3 and cd3
UndeterminedME03981BAntiendomysial antibodiesBispecific antibody
Owner:AMGEN RESEARCH (MUNICH) GMBH
Therapeutically active compounds and their methods of use
ActiveME03690BCombinatorial chemistryMedicinal chemistry
Owner:LES LAB SERVIER SA
Derivatives of 2-aminopyridine as adenosine a2b receptor antagonists and ligands of the melatonin mt3 receptors
UndeterminedME03693BAdenosine A2B Receptor AntagonistsAdenosine
Owner:PALOBIOFARMA SL
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both 2 adrenergic receptor agonist and m3 muscarinic receptor antagonist activities
ActiveME03869BAdrenergic receptor agonistsQuinoline
Owner:ALMIRALL SA
New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
ActiveME03716BPharmaceutical drugCombinatorial chemistry
Owner:VERNALIS (R&D) LTD +1
Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
ActiveME03132BInhalationAdrenergic Agent
Owner:CHIESI FARMACEUTICI SPA
Stabilized formulations containing Anti-interleukin-4 receptor (il-4r) antibodies
ActiveME03135BAntiendomysial antibodiesReceptor
Owner:REGENERON PHARMACEUTICALS INC
Substituted tricyclic compounds as FGFR inhibitors
UndeterminedME03940BDepressantBiochemistry
Owner:INCYTE HOLDINGS CORP
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
ActiveME03857BPyridineKinase inhibition
Owner:ARRAY BIOPHARMA INC
Mono-hydrochloric salts of an inhibitor of histone deacetylase
ActiveME02049BHistone proteinCancer research
Owner:JANSSEN PHARMA NV
Signaling different mcs sets for different bandwidths
UndeterminedME03609BSoftware engineeringMechanical engineering
Owner:QUALCOMM INC
Compositions and methods of inhibting masp-1 and / or masp-3 for the treatment of paroxysmal nocturnal hemoglobinuria
ActiveME03145BParoxysmal AFParoxysmal nocturnal hemoglobinuria
Owner:OMEROS CORP +1
Nasal powder formulation for treatment of hypoglycemia
ActiveME03623BMedicineHypoglycemia
Owner:ELI LILLY & CO
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
UndeterminedME03879BAdrenergicAdrenergic receptor agonists
Owner:CHIESI FARMACEUTICI SPA
New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
ActiveME03764BArylPharmacy medicine
Owner:LES LAB SERVIER SA +1
Alkoxy pyrazoles as soluble guanylate cyclase activators
ActiveME03542BCyclaseBiochemistry
Owner:BOEHRINGER INGELHEIM INT GMBH
Solid forms and formulations of (s)-4-(8-amino-3-(1 -(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
ActiveME03860BPyrazineAcyl group
Owner:ACERTA PHARMA BV
High affinity human antibodies to human nerve growth factor
ActiveME01820BMedicineHigh avidity
Owner:REGENERON PHARMACEUTICALS INC
Process for production and purification of recombinant lysosomal alpha-mannosidase
UndeterminedME03898BBiotechnologyLysosome
Owner:CHIESI FARMACEUTICI SPA
Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
ActiveME01895BDrug aerosolPropanoic acid
Owner:CHIESI FARMACEUTICI SPA
Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
UndeterminedME03927BPharmaceutical drugCombinatorial chemistry
Owner:LES LAB SERVIER SA +1
Efficient selectivity of recombinant proteins
UndeterminedME04059B
Owner:REGENERON PHARMACEUTICALS INC
Heteroaryl carboxamide compounds as inhibitors of ripk2
ActiveME03831BArylDepressant
Owner:BOEHRINGER INGELHEIM INT GMBH
Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution
ActiveME01833BPreservative freePreservative
Owner:LABORATOIRES THEA SAS
Spiro[3h-indole-3,2ยด-pyrrolidin]-2(1H)-one compounds and derivatives as mdm2-p53 inhibitors
UndeterminedME04074BPyrrolidinePerylene derivatives
Owner:BOEHRINGER INGELHEIM INT GMBH
Production of polio virus at high titers for vaccine production
ActiveME01888BPoliomyelitisVaccine Production
Owner:JANSSEN VACCINES & PREVENTION BV
Trimer stabilizing HIV envelope protein mutations
UndeterminedME03882BTrimerVirology
Owner:JANSSEN VACCINES & PREVENTION BV
5-bromo-2,6-di-(1h-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer
ActiveME03705BOncologyCancer treatment
Owner:GLOBAL SPORT KFT +1
Modulators of cystic fibrosis transmembrane conductance regulator
UndeterminedME03876BFibrosisCystic fibrosis transmembrane conductance regulator
Owner:VERTEX PHARMACEUTICALS INC
Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
ActiveME01285BDiseaseSGLT2 Inhibitor
Owner:PFIZER INC
3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatmetn of respiratory diseases
ActiveME03241BDiseaseRespiratory disease
Owner:CHIESI FARMACEUTICI SPA
4 -substituted benzoxaborole compounds and uses thereof
ActiveME03844BBenzoxazoleCombinatorial chemistry
Owner:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD +1
New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
ActiveME03138BPharmaceutical drugCombinatorial chemistry
Owner:VERNALIS (R&D) LTD +1
Ophthalmic compositions containing a nitric oxide releasing prostamide
UndeterminedME03904BNitric oxideOPHTHALMOLOGICALS
Owner:NICOX SA
Human antibodies to fel d1 and methods of use thereof
ActiveME03841BAntiendomysial antibodiesPathology
Owner:REGENERON PHARMACEUTICALS INC
Humanized Anti-il-6 antibodies, compositions, methods and uses
InactiveME03174BAntiendomysial antibodiesBiochemistry
Owner:ELI LILLY & CO +1
Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
ActiveME03696BAntigenBiomedical engineering
Owner:BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC